Skip to content

Pharmacie Forthomme

Active
Private limited companyfounded 1978active for 47 yearsRue de Marche 120, 6600 Bastogne, BelgiumKBO/BCE: BE 0418.997.933
Summary

The computed 12-month bankruptcy probability of Pharmacie Forthomme is 3.0% (moderate). The 2025 annual accounts show negative equity (-€10,209) and a net result of -€53,140. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 14% of 12,502 sector peers (NACE 47, financial year 2025). The company has been active since 1978 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Activity
Retail sale of pharmaceutical products
NACE 47730
#1 oldest company in Bastogne, Wholesale and retail trade sector2 sites
Size
€2.7mtotal assets 2025
Staff
12 FTE
Equity
-€10,209
Loss
-€53,140
Financial health
49 Fair Checked score 2025
Bankruptcy probabilitywithin 12 months
3.0%
Structure
Parent
ExpansionPharma · 100%
Accounts filed 20 days late0 of 3 deeds read
Why 49raises riskNegative equity -€10,209Liquidity: current ratio 0.80, cash €91,390Sector: Retail trade (NACE 47)Size: 12 FTE, total assets €2.7mShow the evidence

Checked score

Score 2025
49 / 100
Fair
Probability in this band: 1.5% to 4.2%
Financially better than 21% of its sector peers (NACE 47, small)
Financial strength · tick = 2024
Weak
Solvency 25-1
equity -0.4% of total assets
Liquidity 41+3
short-term debt 31.7% · cash 3.3%
Profitability 43-13
return on assets -1.9%
Bankruptcy probability, 12 months
3.0% Moderate
0%0.5%1.5%4%10%≥ 25%

About 3 in 100 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.4% (3,692 companies, NACE 47, small)
Last 24 months 11-2024: 2.1%lowest value 12-2024: 2.6%▲ +0.5 percentage points vs 11-2024 01-2025: 2.6%● unchanged vs 12-2024 02-2025: 2.6%● unchanged vs 01-2025 03-2025: 2.6%● unchanged vs 02-2025 04-2025: 2.6%● unchanged vs 03-2025 05-2025: 2.6%● unchanged vs 04-2025 06-2025: 2.2%▼ -0.4 percentage points vs 05-2025 07-2025: 2.2%● unchanged vs 06-2025 08-2025: 2.2%● unchanged vs 07-2025 09-2025: 2.2%● unchanged vs 08-2025 10-2025: 2.2%● unchanged vs 09-2025 11-2025: 2.2%● unchanged vs 10-2025 12-2025: 2.2%● unchanged vs 11-2025 01-2026: 2.2%● unchanged vs 12-2025 02-2026: 2.2%● unchanged vs 01-2026 03-2026: 2.2%● unchanged vs 02-2026 04-2026: 2.3%▲ +0.1 percentage points vs 03-2026 05-2026: 2.3%● unchanged vs 04-2026 06-2026: 2.3%● unchanged vs 05-2026 07-2026: 2.3%● unchanged vs 06-2026 08-2026: 3.8%▲ +1.5 percentage points vs 07-2026highest value 09-2026: 3.0%▼ -0.8 percentage points vs 08-2026 10-2026: 3.0%● unchanged vs 09-2026
No credit on open account
Liquidity insufficient (current ratio 0.8, compared with 0.67 in 2024; short-term debt: 31.7% and cash: 3.3% of total assets), and equity is negative.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, small): better than 10% on solvency, 46% on liquidity, 26% on profitability and 3% on growth.

The bankruptcy probability was computed on 10-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
raises riskneutral
raises risk · Negative equity -€10,209
NBB · annual accounts
raises risk · Liquidity: current ratio 0.80, cash €91,390
NBB · annual accounts
raises risk · Sector: Retail trade (NACE 47)
KBO
raises risk · Size: 12 FTE, total assets €2.7m
The company's size counts in the probability; how much depends on the rest of its profile.
NBB · annual accounts
raises risk · Negative equity
The 2025 annual accounts show negative equity and a net loss.
NBB · annual accounts 2025
Equity per financial year
1819202122232425
2018 to 2025 · latest year -€10,209
neutral · Filed after the deadline
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 20-08-2026, 20 days later. For context: 47% of Belgian companies file late, and of those that file 1 to 90 days late, 2.0% are now in a legal situation other than normal in the KBO (such as bankruptcy, liquidation or dissolution), against 1.66% of all filers. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
20 days late
2024
72 days early
2023
19 days late
2022
6 days early
2021
18 days late
2020
29 days early
2019
27 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 3 days before the deadline; the sector median (NACE 47) for financial year 2024 is on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 18 August (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
10-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · abbreviated…
  2. Annual accounts filedfinancial year 2024 · full…
  3. Annual accounts filedfinancial year 2023 · full…

Key points

  • Risk: Negative equityfinancial year 2025: debts exceed assets -€10,209 View
  • Caution: From profit to loss in 2025after €13,493 in 2024 -€53,140 View
  • Caution: Among the weakest 9% on net resultsector median €28,206 · 12,491 companies -€53,140 View
  • Controlled by ExpansionPharma 100% View
  • Active since 1978founded 09-12-1978 47 years View

By topic

Financials

Financial year
2025
Total assets
€2.7m
Loss
-€53,140
Solvency
-0.4%
Turnover▲ 9.4%
Net result
20182019
Go to Financials

Timeline

Events
50
Since
1980
Next accounts
by 31-07-2027
  1. 25-07-2023Annual accounts filed
  2. 31-12-2022Back to profit
  3. 18-08-2022Annual accounts filed
Go to Timeline

Company details

Sites
2
Legal form
Private limited company
Activity
Retail sale of pharmaceutical productsNACE 47730
Founded
09-12-1978
Year ends
31-12
Peppol
Reachable for e-invoices
Go to Company details

Go further with this company

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.